EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Placebo response and its influencing factors in acne vulgaris: A model‐based meta‐analysis

Jieren Luo iD, Jiesen Yu, Zihao Cai, Haoxiang Zhu, Tingze Liu, Qingshan Zheng, Xiang He, Lujin Li iD

British Journal of Clinical Pharmacology · 2026-07 · 92 (7) · 2171-2182

DOI: 10.1002/bcp.70468 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 18.02.2026. Verfasst von Jieren Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacometrics, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Acne Vulgaris, Placebo Effect, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Shanghai University of Traditional Chinese Medicine Scientific and Technological Development Project, Open Research Program of the State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The high placebo response in acne clinical trials has slowed down the progress of new drug development. Therefore, this study used a model‐based meta‐analysis method to quantitatively analyse the placebo response and explore its influencing factors.

Methods

This study included 21 627 subjects from acne‐related randomized double‐blind placebo‐controlled trials. Pharmacodynamic models were developed for four endpoints: total lesion counts absolute change, noninflammatory lesion counts absolute change, inflammatory lesion counts absolute change and treatment success rate defined by the investigator global assessment scale. Covariate modelling and subgroup analyses were performed to explore influencing factors. Placebo response under different conditions was simulated based on the final model.

Results

Model simulation results showed that for the typical population, after 12 weeks of placebo intervention, their total lesion counts, noninflammatory lesion counts and inflammatory lesion counts were reduced by 19.05 (95% confidence interval: 16.54–21.52), 10.71 (9.18–12.17) and 8.58 (7.55–9.58) from baseline, respectively; the treatment success rate was 11.83% (9.41%–14.35%). Baseline lesion counts, female proportion, Caucasians proportion, sample size, dosage form, type of control drug, skincare programme, number of centres, funding source, study locations and publication year could all influence placebo response. We also used our model to synthesize placebo arms for two single‐arm studies, demonstrating the efficacy superiority of the drugs.

Conclusions

This study quantitatively described the time‐response relationship of placebo in acne clinical trials, revealing the influence of baseline characteristics and trial design characteristics, which could provide evidence for optimizing clinical trial design.

Trial registration

PROSPERO (CRD420250649902).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisPlacebo EffectModels, BiologicalHumansRandomized Controlled Trials as TopicFemaleDouble-Blind MethodTreatment OutcomeMale

Stichwörter der Autor:innen

acnemodel‐based meta‐analysisplacebo response

Autor:innen und Institutionen

  • Center for Pharmacometrics, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Dermatology, Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital, Shanghai, China.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Jieren Luo, Lujin Li

Förderung

  • National Key R&D Program of China
  • Shanghai University of Traditional Chinese Medicine Scientific and Technological Development Project
  • Open Research Program of the State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine
  • Shanghai Municipal Health Commission Smart Healthcare Special Project
  • National Basic Research Program of China

Zitieren

APA

Luo, J., Yu, J., Cai, Z., Zhu, H., Liu, T., Zheng, Q., He, X., & Li, L. (2026). Placebo response and its influencing factors in acne vulgaris: A model‐based meta‐analysis. British Journal of Clinical Pharmacology, 92(7), 2171-2182. https://doi.org/10.1002/bcp.70468

Vancouver

Luo J, Yu J, Cai Z, Zhu H, Liu T, Zheng Q, et al. Placebo response and its influencing factors in acne vulgaris: A model‐based meta‐analysis. British Journal of Clinical Pharmacology. 2026;92(7):2171-2182. doi:10.1002/bcp.70468

BibTeX
@article{Luo2026,
  author = {Luo, Jieren and Yu, Jiesen and Cai, Zihao and Zhu, Haoxiang and Liu, Tingze and Zheng, Qingshan and He, Xiang and Li, Lujin},
  title = {Placebo response and its influencing factors in acne vulgaris: A model‐based meta‐analysis},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  volume = {92},
  number = {7},
  pages = {2171--2182},
  doi = {10.1002/bcp.70468}
}
Kostenlos starten →